ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,900, issued on July 14, was assigned to BIOSION INC. (Nanjing, China).
"Antibodies binding RANKL and uses thereof" was invented by Mingjiu Chen (Nanjing, China), Cathy Xiaoyan Zhong (Nanjing, China) and Shukai Xia (Nanjing, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated monoclonal antibody that specifically binds human RANKL, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody or the antigen-binding portion thereof, an expression vector, a host cell and a method for expressing the antibody or the antigen-binding portion thereof are also provided. A treatment method using an anti-RANKL antibody or t...